NRx Pharmaceuticals receives FDA approval of preservative-free ketamine ahead of November 10 goal date
NRXP•NRx Pharmaceuticals received FDA approval for preservative-free ketamine ahead of the agency’s November 10 goal date. The company said it will manufacture sterile injectable drugs in the U.S. with Nephron Pharmaceuticals.
1. FDA approval
NRx Pharmaceuticals received FDA approval for preservative-free ketamine ahead of the FDA’s November 10 goal date. The company said it will manufacture sterile injectable drugs in the U.S. with Nephron Pharmaceuticals.
